Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuwo Ji

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|July 18, 2006
CEAS: cis-regulatory element annotation systemXuwo Ji, Wei Li, Jun Song, et al.
Plos Genetics|March 30, 2022
RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cellsXinxin Peng, Yikai Luo, Hongyue Li, et al.
Nature Communications|August 7, 2021
Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancerJianzhen Lin, Xinxin Peng, Kun Dong, et al.
Gynecologic Oncology|November 23, 2024
The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancerTong Shu, Yiming Liang, Siwen Zhang, et al.
NPJ Precision Oncology|May 31, 2023
HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patientsLei Li, Yu Gu, Mengpei Zhang, et al.
Science Bulletin|December 7, 2025
Machine learning-based diagnosis of uterine myomas and sarcomas using tumor-educated platelet transcriptomics: a retrospective multicenter studyXudong Liu, Roujie Huang, Hua Yang, et al.
Science Advances|March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapyZiyu Li, Xiangyu Gao, Xinxin Peng, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|July 18, 2006
CEAS: cis-regulatory element annotation systemXuwo Ji, Wei Li, Jun Song, et al.
Plos Genetics|March 30, 2022
RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cellsXinxin Peng, Yikai Luo, Hongyue Li, et al.
Nature Communications|August 7, 2021
Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancerJianzhen Lin, Xinxin Peng, Kun Dong, et al.
Gynecologic Oncology|November 23, 2024
The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancerTong Shu, Yiming Liang, Siwen Zhang, et al.
NPJ Precision Oncology|May 31, 2023
HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patientsLei Li, Yu Gu, Mengpei Zhang, et al.
Science Bulletin|December 7, 2025
Machine learning-based diagnosis of uterine myomas and sarcomas using tumor-educated platelet transcriptomics: a retrospective multicenter studyXudong Liu, Roujie Huang, Hua Yang, et al.
Science Advances|March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapyZiyu Li, Xiangyu Gao, Xinxin Peng, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Pageof 1